How Long Do Semaglutide Side Effects Last?

Here's the honest answer: semaglutide's most common side effects are digestive, and they cluster around two moments — starting the medication and each dose increase. The prescribing information for branded semaglutide (Wegovy) does not put a fixed number of weeks on how long they last, and individual experience varies. What it does document is which effects are most common, and why the dose is raised so gradually.^[1]

In Wegovy's adult clinical trials, the most common adverse reactions were nausea (44%), diarrhea (30%), vomiting (24%), constipation (24%), abdominal pain (20%), headache (14%), and fatigue (11%).^[1] Most are gastrointestinal. If they aren't easing for you, a licensed provider can slow your dose escalation, hold at a lower dose, or adjust your plan.

Why side effects happen at all

Semaglutide slows how quickly your stomach empties and turns down appetite signaling.^[2] Those are the intended effects — and they're also why your digestive system needs an adjustment period. Early nausea, fullness, and bowel changes are usually your body recalibrating to a new normal, not a sign something is wrong. To reduce the risk of gastrointestinal reactions, the label starts the dose low and steps it up slowly.^[1]

The dosing schedule that shapes side effects

The prescribing information sets a deliberately gradual escalation for the once-weekly injection, raising the dose every 4 weeks so your system can adjust at each level:^[1]

• Weeks 1–4: 0.25 mg once weekly — the starting dose
• Weeks 5–8: 0.5 mg once weekly
• Weeks 9–12: 1 mg once weekly
• Weeks 13–16: 1.7 mg once weekly
• Week 17 onward: 2.4 mg once weekly — the usual maintenance dose

Because each step up is a new, higher dose, a brief wave of mild digestive symptoms in the days after an increase is common — which is exactly why the schedule moves in small, spaced-out steps. The label says that if you don't tolerate a dose, escalation can be delayed for 4 weeks, and if several doses are missed it can be restarted at a lower dose to reduce the risk of gastrointestinal reactions.^[1] Those adjustments are your provider's call, made with you.

Side effect by side effect

• Nausea — the most common effect, reported by 44% of patients in trials.^[1] Smaller meals, slower eating, and avoiding greasy or heavy foods help most people. If your provider prescribes it, anti-nausea medication (ondansetron) is included in every Ladies First plan.
• Constipation or diarrhea — both common in trials (24% and 30%).^[1] Fiber, fluids, and movement do more than most people expect.
• Fatigue and headaches — reported by 11% and 14% of patients.^[1] Hydration and consistent meals help, since you're eating less than your body is used to.
• Reduced appetite — this one isn't a side effect to wait out; it's the mechanism.^[2] The dramatic suppression of the early weeks usually softens into steadier, more manageable hunger control.

What helps most during the adjustment

• Eat smaller portions, slowly — your stomach is emptying more slowly, and large meals are the #1 avoidable trigger
• Choose gentler foods early on; hold off on rich, fried, or spicy meals for a few weeks
• Stay ahead on hydration, especially on days nausea shows up
• Keep your injection day consistent
• Don't skip eating entirely — an empty stomach can make nausea worse

When it's not "just adjustment"

The prescribing information flags certain reactions as reasons to seek medical attention. Contact a medical provider promptly if you experience:^[1]

• Vomiting or diarrhea that leaves you unable to keep fluids down — the label notes gastrointestinal reactions can lead to dehydration and, in turn, affect kidney function, and advises monitoring especially during dose initiation and escalation
• Signs of dehydration — dizziness, very dark urine, or dry mouth
• Side effects that are worsening after the first weeks instead of improving

Seek immediate medical care for persistent or severe abdominal pain that doesn't ease — sometimes radiating to the back, with or without nausea or vomiting — which the label lists as a possible sign of acute pancreatitis; or for signs of a serious allergic reaction such as facial or throat swelling or trouble breathing, which the label notes can include anaphylaxis and angioedema.^[1] Both are reasons to stop and get help rather than wait and see.

Side effects shouldn't be endured in silence

One of the most common mistakes is quietly suffering through symptoms for months — or quitting the medication entirely — without a conversation. Most persistent side effects have workable answers: slowing the dose escalation, holding at a lower dose, adding anti-nausea support, adjusting eating patterns, or switching medications altogether. That's precisely what ongoing provider follow-up is for, and it's included in every plan. Whether your dose changes, holds, or your medication switches is always your provider's call, made with you.

The bottom line

Semaglutide's most common side effects are digestive, and they tend to cluster around starting out and each dose increase — which is why the label's schedule raises the dose slowly, every 4 weeks.^[1] The label doesn't promise a fixed end date, and experiences genuinely vary. If yours is tracking worse than you expected, that's not a personal failing or a reason to give up — it's a signal to loop in your provider.

Start with support built in. Answer a few health questions online — about 3 minutes, free — and a medical provider licensed in your state reviews your history, usually within 48 hours. Every plan includes ongoing provider follow-ups and messaging, so the adjustment period is never something you navigate alone. Your treatment ships only after a licensed medical provider approves your plan.

Keep reading

• Explore the weight program
• Wegovy side effects, honestly
• Are semaglutides safe?

Sources

1. Wegovy® (semaglutide) Prescribing Information — U.S. FDA, via DailyMed. Adverse-reaction incidence (Table 3), dosage-escalation schedule (Table 1, §2.2), and Warnings & Precautions (§5.2 acute pancreatitis, §5.5 acute kidney injury due to volume depletion, §5.7 hypersensitivity). dailymed.nlm.nih.gov
2. Semaglutide. StatPearls [Internet]. National Library of Medicine, NCBI Bookshelf ID NBK603723. ncbi.nlm.nih.gov/books/NBK603723